These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36225496)

  • 41. Susceptibility testing for aztreonam plus ceftazidime/avibactam combination: A general guidance for clinical microbiology laboratories in India.
    Bakthavatchalam YD; Walia K; Veeraraghavan B
    Indian J Med Microbiol; 2022; 40(1):3-6. PubMed ID: 34949482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
    Singh R; Kim A; Tanudra MA; Harris JJ; McLaughlin RE; Patey S; O'Donnell JP; Bradford PA; Eakin AE
    J Antimicrob Chemother; 2015 Sep; 70(9):2618-26. PubMed ID: 26024868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of ceftazidime/avibactam combined with aztreonam in the NDM-producing Klebsiella pneumoniae bloodstream and intestinal infections in a NK/T lymphoma patient with agranulocytosis during autologous hematopoietic stem cell transplantation: a case report.
    Liu S; Lin Q; Ouyang L; Zhou C; Wang H
    Eur J Clin Microbiol Infect Dis; 2022 Nov; ():1-4. PubMed ID: 36371600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Simple Disk Stacking Plus Micro-Elution Method for Rapid Detection of the Synergistic Effect of Aztreonam and Ceftazidime/Avibactam Against Metallo-β-Lactamase Producing Enterobacterales.
    Liu Z; Hang X; Yan T; Chu W; Gong Z; Liu Y; Dai Y; Yang M; Li J; Zhou Q
    Infect Drug Resist; 2023; 16():1537-1543. PubMed ID: 36937146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination antibiotic therapy for treatment of a patient with infected prosthesis and peri-prosthetic abscess due to
    Cespedes Santana M; Wong TT; Urban C; Mariano N; Burns J; Rodriguez GD; Goldwyn E; Prasad N; Segal-Maurer S
    IDCases; 2022; 27():e01385. PubMed ID: 35070715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens.
    Wenzler E; Deraedt MF; Harrington AT; Danizger LH
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):352-354. PubMed ID: 28602518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic Diversity and in vitro Activity of Aztreonam/Avibactam and Ceftazidime/Avibactam Against Carbapenem-Resistant
    Sun S; Chen K; Kong X; Tian W; Niu S
    Infect Drug Resist; 2022; 15():2243-2251. PubMed ID: 35510161
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Yu W; Xiong L; Luo Q; Chen Y; Ji J; Ying C; Liu Z; Xiao Y
    Front Cell Infect Microbiol; 2021; 11():780365. PubMed ID: 34900759
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Karlowsky JA; Kazmierczak KM; de Jonge BLM; Hackel MA; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
    Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW
    Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
    Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
    J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).
    Ko WC; Stone GG
    Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):14. PubMed ID: 32238155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of aztreonam, ceftazidime-avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis.
    Mularoni A; Mezzatesta ML; Pilato M; Medaglia AA; Cervo A; Bongiorno D; Aprile A; Luca A; Stefani S; Grossi P
    Int J Infect Dis; 2021 Jul; 108():510-512. PubMed ID: 34091004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.
    van Duin D; Bonomo RA
    Clin Infect Dis; 2016 Jul; 63(2):234-41. PubMed ID: 27098166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope.
    Avery LM; Nicolau DP
    Int J Antimicrob Agents; 2018 Nov; 52(5):688-691. PubMed ID: 30044946
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens.
    Bush K
    Int J Antimicrob Agents; 2015 Nov; 46(5):483-93. PubMed ID: 26498989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae.
    Niu S; Wei J; Zou C; Chavda KD; Lv J; Zhang H; Du H; Tang YW; Pitout JDD; Bonomo RA; Kreiswirth BN; Chen L
    J Antimicrob Chemother; 2020 Mar; 75(3):559-565. PubMed ID: 31722380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of New Delhi Metallo-Beta-Lactamase-1 (NDM-1) in carbapenem- resistant Klebsiella pneumoniae isolated from a university hospital in Iran.
    Fazeli H; Norouzi-Barough M; Ahadi AM; Shokri D; Solgi H
    Hippokratia; 2015; 19(3):205-9. PubMed ID: 27418777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.